5-36251411-T-C
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_145000.5(RANBP3L):c.1256A>G(p.Asn419Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_145000.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RANBP3L | ENST00000296604.8 | c.1256A>G | p.Asn419Ser | missense_variant | Exon 13 of 14 | 1 | NM_145000.5 | ENSP00000296604.3 | ||
RANBP3L | ENST00000502994.5 | c.1331A>G | p.Asn444Ser | missense_variant | Exon 14 of 15 | 2 | ENSP00000421853.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 30
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.1331A>G (p.N444S) alteration is located in exon 14 (coding exon 14) of the RANBP3L gene. This alteration results from a A to G substitution at nucleotide position 1331, causing the asparagine (N) at amino acid position 444 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at